Your browser doesn't support javascript.
loading
Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.
Chew, Emily Y; Clemons, Traci E; Jaffe, Glenn J; Johnson, Charles A; Farsiu, Sina; Lad, Eleonora M; Guymer, Robyn; Rosenfeld, Philip; Hubschman, Jean-Pierre; Constable, Ian; Wiley, Henry; Singerman, Lawrence J; Gillies, Mark; Comer, Grant; Blodi, Barbara; Eliott, Dean; Yan, Jiong; Bird, Alan; Friedlander, Martin.
  • Chew EY; Division of Epidemiology and Clinical Application, National Eye Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: echew@nei.nih.gov.
  • Clemons TE; The Emmes Corporation, Rockville, Maryland.
  • Jaffe GJ; Duke Reading Center, Duke University, Durham, North Carolina.
  • Johnson CA; Neurotech Pharmaceutical, Cumberland, Rhode Island.
  • Farsiu S; Duke Reading Center, Duke University, Durham, North Carolina.
  • Lad EM; Duke Reading Center, Duke University, Durham, North Carolina.
  • Guymer R; Centre for Eye Research, University of Melbourne, Melbourne, Australia.
  • Rosenfeld P; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
  • Hubschman JP; Jules Stein Eye Institute, University of California, Los Angeles, California.
  • Constable I; Lions Eye Institute, University of Western Australia, Perth, Australia.
  • Wiley H; Division of Epidemiology and Clinical Application, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Singerman LJ; Retina Associates of Cleveland, Cleveland, Ohio.
  • Gillies M; Save Sight Institute, University of Sydney, Sydney, Australia.
  • Comer G; Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan.
  • Blodi B; Department of Ophthalmology, University of Wisconsin, Madison, Wisconsin.
  • Eliott D; Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.
  • Yan J; Department of Ophthalmology, Emory University, Atlanta, Georgia.
  • Bird A; Department of Inherited Eye Disease, Moorfields Eye Hospital, London, United Kingdom.
  • Friedlander M; Department of Molecular Medicine, The Scripps Research Institute; Division of Ophthalmology, Scripps Clinic; and the Lowy Medical Research Institute, La Jolla, California.
Ophthalmology ; 126(4): 540-549, 2019 04.
Article en En | MEDLINE | ID: mdl-30292541

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Degeneración Retiniana / Factor Neurotrófico Ciliar / Implantes de Medicamentos / Telangiectasia Retiniana / Tratamiento Basado en Trasplante de Células y Tejidos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Degeneración Retiniana / Factor Neurotrófico Ciliar / Implantes de Medicamentos / Telangiectasia Retiniana / Tratamiento Basado en Trasplante de Células y Tejidos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article